Effectively treating patients devastated by total joint infection via proprietary antibiotic delivery to reduce cost, morbidity and risk of amputation or death
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free